Using the optimized siRNA-loaded CL4H6-LNPs to target TAMs, they achieved an an-titumor therapeutic effect in a human tumor xenograft model through the silencing of signal STAT3 and HIF-1α, thereby increasing the number of M1-type macrophages 70. The gene discussed is STAT3; the disease is neoplasm.